Collegium Pharmaceutical Inc (COLL) — Cash Flow Reinvestment Rate
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting $31.06 Million (capex $188.00K plus investments $-30.87 Million) from operating cash flow of $78.44 Million. Check COLL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Collegium Pharmaceutical Inc Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Collegium Pharmaceutical Inc across 7 annual periods. Explore COLL debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year capital reinvestment analysis for Collegium Pharmaceutical Inc. For live market cap and broader valuation context, see COLL company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $289.41 Million | $204.98 Million | $1.65 Million | ▲ +723.3% |
| 2023 | 0.17x | $47.12 Million | $274.75 Million | $461.00K | ▼ -96.3% |
| 2022 | 4.63x | $575.31 Million | $124.23 Million | $1.62 Million | ▲ +12234.8% |
| 2021 | 0.04x | $3.89 Million | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 7.96x | $747.54 Million | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.46x | $12.88 Million | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.29x | $48.71 Million | $169.39 Million | $24.35 Million | — |